ArticleEuropean journal of cancer (Oxford, England : 1990)2020

Survivorship in immune therapy: Assessing toxicities, body composition and health-related quality of life among long-term survivors treated with antibodies to programmed death-1 receptor and its ligand.

James Randall Patrinely et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.